BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36680216)

  • 1. Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion.
    Salnikov M; Prusinkiewicz MA; Lin S; Ghasemi F; Cecchini MJ; Mymryk JS
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.
    Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS
    Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers.
    Sun Q; Fu Y; Chen X; Li L; Wu H; Liu Y; Xu H; Zhou G; Fan X; Xia H
    Gut Liver; 2022 Nov; 16(6):875-891. PubMed ID: 35611665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis.
    Salnikov MY; Wang E; Christensen E; Prusinkiewicz MA; Shooshtari P; Mymryk JS
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
    Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
    Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis.
    Salnikov MY; Fonseca GJ; Mymryk JS
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Prognostic Values of CXCL Family in Epstein-Barr Virus Associated Gastric Cancer.
    Mu L; Hu S; Li G; Wu P; Ren C; Lin T; Zhang S
    Oxid Med Cell Longev; 2022; 2022():2218140. PubMed ID: 35693706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma.
    Gong LP; Chen JN; Xiao L; He Q; Feng ZY; Zhang ZG; Liu JP; Wei HB; Shao CK
    Hum Pathol; 2019 Mar; 85():82-91. PubMed ID: 30448221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway.
    Dong M; Gong LP; Chen JN; Zhang XF; Zhang YW; Hui DY; Zhao XX; Wu XY; Shao CK
    Cell Oncol (Dordr); 2020 Oct; 43(5):901-913. PubMed ID: 32533512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
    Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
    Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-myc and PCNA in Epstein-Barr virus-associated gastric carcinoma.
    Zhu S; Sun P; Zhang Y; Yan L; Luo B
    Exp Ther Med; 2013 Apr; 5(4):1030-1034. PubMed ID: 23599727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma.
    Zhang NN; Chen JN; Xiao L; Tang F; Zhang ZG; Zhang YW; Feng ZY; Jiang Y; Shao CK
    Sci Rep; 2015 Dec; 5():18057. PubMed ID: 26673957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
    Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
    World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy.
    Ma J; Li J; Hao Y; Nie Y; Li Z; Qian M; Liang Q; Yu J; Zeng M; Wu K
    Oncotarget; 2017 Sep; 8(40):67094-67103. PubMed ID: 28978018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma.
    Chen ZH; Yan SM; Chen XX; Zhang Q; Liu SX; Liu Y; Luo YL; Zhang C; Xu M; Zhao YF; Huang LY; Liu BL; Xia TL; Xu DZ; Liang Y; Chen YM; Wang W; Yuan SQ; Zhang HZ; Yun JP; Zhai WW; Zeng MS; Bai F; Zhong Q
    Genome Med; 2021 Sep; 13(1):146. PubMed ID: 34493320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
    Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P
    Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
    Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
    Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
    Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
    Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.